Comparison of in vivo and in vitro inhibition of the anaphylactic mechanism by beta-adrenergic stimulants and disodium cromoglycate.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000605:Amino Alcohols / Q000627:therapeutic use*; D000707:Anaphylaxis / Q000188:drug therapy*; D000818:Animals; D002867:Chromones / Q000627:therapeutic use*; D003911:Dextrans; D005260:Female; D006168:Guinea Pigs; D006632:Histamine / Q000032:analysis; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology; D007082:Ileum / Q000187:drug effects; D007073:Immunoglobulin E; D007545:Isoproterenol / Q000627:therapeutic use*; D008168:Lung / Q000276:immunology; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology; D008925:Mites; D010323:Passive Cutaneous Anaphylaxis; D010537:Peritoneum / Q000166:cytology; D051381:Rats; D012882:Skin Tests; D013566:Sympathomimetics / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D000605:Amino Alcohols; D002867:Chromones; D003911:Dextrans; D013566:Sympathomimetics; D007073:Immunoglobulin E; D006632:Histamine; D007545:Isoproterenol